,0,1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16
0,분기,2019q1,2019q2,2019q3,2019q4,2020q1,2020q2,2020q3,2020q4,2021q1,2021q2,2021q3,2021q4,2022q1,2022q2,2022q3,2022q4
1,N/C/A,1487/35/30,2012/52/31,1903/40/30,2193/59/30,2225/47/28,2660/59/30,2165/45/31,2918/74/32,2490/68/30,2314/78/32,2100/65/30,2530/73/33,2431/67/33,2469/88/35,1541/52/33,2990/75/32
2,1,플랫폼기술기반,면역관문억제,계획예방정비,고객관계관리,기업데이터가공,면역관문억제,온라인광고,신약연구개발,단백질표적,발전경상정비,금융정보서비스,면역관문억제,핵융합발전,반도체후공정,자가면역질환,간편현금결제
3,2,전자가격표,후보물질도출,전시문화산업,유전분석기술,헬스케어미디어플랫폼,비소세포폐암,아토피피부염,신약후보물질,특수단말시스템,암환자대상,비소세포폐암,차백신연구,전기차충전,디지털트랜스포메이션,비소세포폐암,공동연구개발
4,3,신차사이클도래,닷컴비즈니스,동영상광고,염기서열분석,온라인쇼핑,단일클론항체,기술이전계약,전시문화산업,미디어렙사업,인체적용시험,감마델타세포,신약연구개발,변동사항전망,전기차충전,약물상호작용,자가면역질환
5,4,항원제시세포,개인신용정보,러시아월드컵,면역관문억제,플랫폼기술기반,온라인쇼핑,플랫폼기술기반,유전분석기술,희귀의약지정,환경에너지기업,부동산권리,기술이전계약,건강기능식품,시스템반도체테스트,환경변화전략,아토피피부염
6,5,법인세자산,항암면역치료,기술이전계약,유전분석서비스,출처케어랩스한국,디지털광고시장,디지털뉴딜정책,플랫폼기술기반,디지털트랜스포메이션,계획예방정비,산권리조사,유전분석서비스,노하우기반,비즈니스부스팅사업,자재가격상승,개인정보보호
